Ketamine-Assisted Psychotherapy in Phoenix: How KAP Can Help Depression, PTSD, and Anxiety

Mental health treatment continues to evolve, and one of the most promising newer approaches is ketamine-assisted psychotherapy (KAP). At Baseline Psychiatry in Phoenix, Arizona, this treatment combines low-dose ketamine with guided therapy to help patients break through difficult mental health symptoms when traditional treatments have not worked.

Below is a simple overview of how KAP works and who may benefit.

What Is Ketamine?

Ketamine is a medication doctors have safely used in hospitals for over 50 years as an anesthetic. Researchers later discovered that low doses of ketamine can rapidly improve symptoms of depression by working on brain pathways involved in mood regulation. Studies show ketamine may improve depression symptoms within hours or days rather than the weeks often required for traditional antidepressants.

Ketamine works differently from most psychiatric medications. Instead of mainly affecting serotonin, ketamine blocks the NMDA receptor, which increases glutamate activity and promotes new brain connections, a process known as neuroplasticity. This may help the brain “reset” unhealthy thought patterns.
(Zarate et al., 2006; Duman & Aghajanian, 2012)

What Is Ketamine-Assisted Psychotherapy (KAP)?

Ketamine-assisted psychotherapy (KAP) combines ketamine treatment with structured therapy sessions. The medication can temporarily increase mental flexibility and emotional insight, allowing therapy to be more effective.

KAP usually involves three stages:

Preparation – A clinician discusses goals, expectations, and safety.
Ketamine session – The medication is given in a monitored medical setting.
Integration therapy – A therapist helps patients process insights from the experience.

Research suggests combining psychotherapy with ketamine may produce longer-lasting improvements than medication alone.
(Dore et al., 2019)

Conditions KAP May Help Treat

Research suggests ketamine therapy may benefit several mental health conditions:

Treatment-Resistant Depression

Ketamine is best known for helping patients whose depression has not improved with traditional medications. Studies show response rates significantly higher than many standard treatments.
(Zarate et al., 2006)

Suicidal Thoughts

Ketamine has been shown to rapidly reduce suicidal ideation in many patients, which is why some hospitals use it in severe psychiatric crises.
(Wilkinson et al., 2018)

PTSD and Trauma

Ketamine may help patients process traumatic memories with less emotional overwhelm, which can improve therapy outcomes.
(Feder et al., 2014)

Anxiety Disorders

Early studies show improvement in generalized anxiety, social anxiety, and panic symptoms following ketamine treatment.
(Glue et al., 2018)

Addiction and Substance Use

Researchers are studying ketamine’s potential to help disrupt addictive behavior patterns and support recovery.
(Dakwar et al., 2019)

What a Ketamine Therapy Session Feels Like

During treatment, patients may experience:

• deep relaxation
• changes in perception
• vivid thoughts or insights
• a dream-like state

These effects typically last 45–90 minutes. Patients remain monitored in a safe medical environment throughout the session.

Afterward, therapy helps patients integrate what they experienced and apply it to real-life emotional healing.

Ketamine Therapy partnership with Baseline Psychiatry

At Baseline Psychiatry in Phoenix, ketamine-assisted psychotherapy is offered as part of a comprehensive mental health approach. Treatment plans are individualized and designed to support patients dealing with depression, anxiety, trauma, and other conditions.

If you are struggling with symptoms that have not improved with traditional medications, ketamine therapy may be an option worth exploring.

References

Duman RS, Aghajanian GK. Synaptic dysfunction in depression. Science. 2012.
Zarate CA et al. A randomized trial of an NMDA antagonist in treatment-resistant depression. Arch Gen Psychiatry. 2006.
Dore J et al. Ketamine-assisted psychotherapy: A systematic review. Journal of Psychoactive Drugs. 2019.
Feder A et al. Efficacy of ketamine in PTSD. JAMA Psychiatry. 2014.
Wilkinson ST et al. The effect of ketamine on suicidal ideation. Biological Psychiatry. 2018.
Glue P et al. Ketamine’s antidepressant and anxiolytic effects. Depression and Anxiety. 2018.
Dakwar E et al. Ketamine for substance use disorders. American Journal of Psychiatry. 2019.